Non-Cystic Fibrosis Bronchiectasis Pipeline Insight Over 15 Companies are Progressing Through to Improve the Treatment Landscape DelveInsight
| HLHIX Fund | USD 30.37 0.11 0.36% |
Slightly above 54% of Allianzgi Health's investor base is interested to short. The analysis of overall sentiment of trading Allianzgi Health Sciences mutual fund suggests that many investors are impartial at this time. Allianzgi Health's investing sentiment can be driven by a variety of factors including economic data, Allianzgi Health's earnings reports, geopolitical events, and overall market trends.
Allianzgi |
The non-cystic fibrosis bronchiectasis market is driven by rising prevalence linked to respiratory infections, autoimmune diseases, and COPD. Increasing awareness among healthcare providers and patients facilitates early diagnosis and treatment. Advancements in drug development, including new therapies and effective mucolytics, are expanding treatment options. Ongoing RD efforts by pharmaceutical companies address unmet medical needs, further driving market growth.New York, USA, Nov. 13, 2024
Read at finance.yahoo.com
 |
Allianzgi Health Fundamental Analysis
We analyze Allianzgi Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allianzgi Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allianzgi Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Allianzgi Health is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Allianzgi Health Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allianzgi Health mutual fund to make a market-neutral strategy. Peer analysis of Allianzgi Health could also be used in its relative valuation, which is a method of valuing Allianzgi Health by comparing valuation metrics with similar companies.
Peers
Allianzgi Health Related Equities
| RETSX | Tax-managed | 0.52 | ||||
| JLCVX | Fundamental Large | 0.45 | ||||
| VAAGX | Virtus Nfj | 0.17 | ||||
| LBWAX | Legg Mason | 0.13 | ||||
| RCLIX | T Rowe | 0.31 | ||||
| SBQAX | Americafirst Large | 0.41 |
Other Information on Investing in Allianzgi Mutual Fund
Allianzgi Health financial ratios help investors to determine whether Allianzgi Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allianzgi with respect to the benefits of owning Allianzgi Health security.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |